Evidence map›Paper›PMID 40963756›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Cumulative Genetic Risk for Asthma Contributes to Disease Severity in Children with Asthma living in Urban Environments.

Matthew Dapas, William Wentworth-Sheilds, Emma E Thompson, Rajesh Kumar, Elizabeth Lippner, Robert A Wood, George T O'Connor, Gurjit K Khurana Hershey, Rebecca S Gruchalla, Andrew H Liu and 13 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Matthew DapasDivision of Rheumatology, Department of Medicine; Center for Human Immunobiology; Center for Genetic Medicine; Northwestern University Feinberg School of Medicine, Chicago, IL.ORCID 0000-0002-8004-8535
William Wentworth-SheildsDepartment of Human Genetics, University of Chicago, Chicago, IL.
Emma E ThompsonDepartment of Human Genetics, University of Chicago, Chicago, IL.
Rajesh KumarAnn and Robert H. Lurie Children's Hospital; Division of Allergy and Immunology, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL.
Elizabeth LippnerAnn and Robert H. Lurie Children's Hospital; Division of Allergy and Immunology, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL.
Robert A WoodDepartment of Pediatrics, Johns Hopkins University Medical Center, Baltimore, MD.
George T O'ConnorPulmonary Center, Boston University School of Medicine, Boston, MA.
Gurjit K Khurana HersheyDivision of Asthma Research, Cincinnati Children's Hospital, Cincinnati, OH.
Rebecca S GruchallaDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Andrew H LiuChildren's Hospital Colorado; Department of Allergy and Immunology, University of Colorado School of Medicine, Aurora, CO.
Edward M ZorattiDepartments of Medicine and Public Health Sciences, Henry Ford Health and Michigan State University College of Human Medicine, Detroit, MI.
Leonard B BacharierMonroe Carell Jr. Children's Hospital at Vanderbilt University Medical Center, Nashville, TN.
Stephanie Lovinsky-DesirDepartment of Pediatrics and Environmental Health Sciences, Columbia University, New York, NY.
Michele A GillDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO.
William J SheehanChildren's National Hospital; Division of Allergy and Immunology, George Washington University School of Medicine and Health Sciences, Washington, DC.
Shilpa J PatelDivision of Emergency Medicine, Children's National Hospital, Washington, DC.
Matthew C AltmanDepartment of Allergy and Infectious Diseases, University of Washington, Seattle, WA.
James E GernDepartments of Pediatrics and Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Cynthia M VisnessRho Inc., Durham, NC.
Peter J GergenNational Institute of Allergy and Infectious Diseases, Bethesda, MD.
Patrice M BeckerNational Institute of Allergy and Infectious Diseases, Bethesda, MD.
Daniel J JacksonDepartments of Pediatrics and Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Carole OberDepartment of Human Genetics, University of Chicago, Chicago, IL.

Funding

Transplantation GroupUM2AI117870 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI DAVID, GLORIA · 2015 to 2023
$208.1M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Inner City Asthma consortium 3 (ICAC3)UM1AI114271 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E., JACKSON, DANIEL J · 2014 to 2021
$79.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR000075NCATS NIH HHS UL1 TR000077NCATS NIH HHS UL1 TR000150NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000451NCATS NIH HHS UL1 TR001079NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR001105NCATS NIH HHS UL1 TR001422NCATS NIH HHS UL1 TR001425NCATS NIH HHS UL1 TR001430NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR001876NCATS NIH HHS UL1 TR002345NCATS NIH HHS UL1 TR002535NCRR NIH HHS M01 RR000052NCRR NIH HHS M01 RR000071NCRR NIH HHS M01 RR000533NCRR NIH HHS UL1 RR024156NCRR NIH HHS UL1 RR024992NCRR NIH HHS UL1 RR025741NCRR NIH HHS UL1 RR025771NCRR NIH HHS UL1 RR025780NIAID NIH HHS HHSN272200900052CNIAID NIH HHS HHSN272201000052INIAID NIH HHS UM1 AI114271NIAID NIH HHS UM1 AI160040NIAID NIH HHS UM2 AI117870
6 · The paper itself

Abstract

Background: Childhood-onset asthma is highly heritable, with nearly 200 risk loci identified in genome-wide association studies. Aggregated polygenic risk scores can be used to quantify genetic predisposition to asthma, but their power to predict asthma severity in multi-ancestral groups has not been determined. Objective: Our aim was to examine the predictive power of biobank-derived asthma polygenic risk scores in children with asthma living in urban environments. Methods: We generated polygenic risk scores for asthma, derived from a large-scale genome-wide association meta-analysis, in four multi-ancestry asthma study cohorts of children living in urban environments. We assessed genetic predictions across different subphenotypes of asthma and tested for associations between genetic asthma risk and measures of asthma severity. Results: Genetic asthma prediction was significantly stronger for more symptomatic asthma phenotypes (P<0.001). Polygenic risk scores were significantly higher in difficult-to-control vs. easy-to-control asthma (P=0.02). Genetic risk was also significantly associated with more frequent exacerbations (P=0.03), higher blood eosinophil levels (P=0.01), and lower lung function (P<0.001). Conclusion: Cumulative genetic risk for asthma is associated with disease severity and exacerbation risk in children with asthma living in urban environments.

Identifiers

PMID40963756
PMCPMC12440043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.